81
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Crystal structure, DNA interaction, and antiproliferative activity of the cobalt(II) complex of demethylcantharate and imidazole

, , , , &
Pages 920-930 | Received 23 Aug 2010, Accepted 31 Dec 2010, Published online: 26 Feb 2011
 

Abstract

A new cobalt(II) complex, [Co(C3H4N2)(C8H8O5)(H2O)2]·2H2O, of demethylcantharate(7-oxabicyclo[2,2,1]heptane-2,3-dicarboxylate, C8H8O5) with imidazole has been synthesized from cobalt chloride, demethylcantharidin (NCTD) and imidazole. The complex was characterized by elemental analysis, IR, and X-ray single crystal diffraction. The complex crystallized in the monoclinic crystal system and P21/m space group with a = 0.634790(10) nm, b = 0.963030(10) nm, c = 1.221770(10) nm, α = 90°, β = 95.9700(10)°, γ = 90°, V = 0.742844(15) nm3, Mr  = 383.22, Dc  = 1.713 g cm−3, Z = 2, F(0 0 0) = 398, μ = 1.206 mm−1, the final R = 0.0291, and wR = 0.0837 [I > 2σ(I )]. The interaction of the complex with deoxyribonucleic acid (DNA) was studied by electronic absorption spectra, fluorescence spectra, and viscosity measurements, which indicate that the complex binds to calf thymus DNA through a partially intercalative mode. The binding constant K b for the complex was 2.62 × 104 L mol−1. The antiproliferation activity test showed that the complex has high antiproliferative ability against human hepatoma cells SMMC7721 (with IC50 being 42.8 ± 0.9 µmol L−1) and human lung cancer cells A549 (with IC50 being 65.1 ± 3.2 µmol L−1). The inhibition rates of the complex are much higher than those of NCTD.

Acknowledgments

Financial support from Natural Science Foundation of Zhejiang Province (grant no. Y407301) is gratefully acknowledged.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.